Search Results 2631-2640 of 15224 for Alternative

  1. A Study to Evaluate Trabectedin with Olaparib in Advanced Unresectable or Metastatic Sarcoma - Mayo Clinic

    Additional active malignancy or treatment for alternative cancer (excluding non-melanoma skin cancer) requiring treatment within the past two years.

  2. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    - Patients requiring inhaled glucocorticoids but have no other alternative treatment option if their condition deteriorates during the study. - Clinically ...

  3. Study finds similar cardiovascular outcomes for generic, brand-name drugs for hypothyroidism

    JACKSONVILLE, Fla. — A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease ...

  4. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

    ... alternative active anti-MF therapy; or -at any time during the randomized treatment period if they meet the protocol-defined criteria for radiographically ...

  5. Hematology - Clinical trials

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  6. Idiopathic transverse myelopathy: Pinpointing the cause - Mayo Clinic

    "We also see patients who were put on immunosuppressant medications for a suspected inflammatory myelopathy who ultimately received an alternative diagnosis ...

  7. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

    without an alternative medical cause or confirmed by more than one follicle stimulating hormone [FSH] measurement), or naturally or surgically sterile ...

  8. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    ... alternative medical cause) prior to screening. In addition, at least 2 high follicle stimulating hormone (FSH) measurements in the postmenopausal range must ...

  9. Study for Patients Previously Enrolled in Studies With Pelabresib - Mayo Clinic

    ... alternative medical cause) are eligible. NOTE: Female patients who have been amenorrheic for at least 12 months resulting from chemo/radiotherapy are ...

  10. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    Total abstinence for the same study period is an acceptable alternative. Exclusion Criteria. Chemotherapy, immunotherapy (including interferon), or biological ...